Medtech Insights UK: the changing NHS, mastering NICE evaluation

Significant changes in the organization of the NHS and new government initiatives to grow the medtech and biotech industries in the UK are creating new opportunities for companies seeking to enter the UK medtech market.
UK has one of the largest medical device markets in the world, valued at US $8.9 billion in 2012 with growth of 6.0% per annum expected by 2017. In addition, the UK is committed to internal growth and innovation of its medtech and biotech industries with the announcement of substantial tax and R&D funding benefits for UK-based companies and Swiss companies considering setting up in the UK.

Large potential market
Medtech Switzerland, in cooperation with the British Embassy Berne, UK Trade and Investment, and the Swiss Business Hub UK, will bring partakers an afternoon seminar and hands-on workshop which will answer three simple questions:

  • How is the NHS changing?
  • What does this mean for Swiss medtech companies?
  • How should a medtech company engage with the National Institute for Clinical Excellence?

May 29, 2013 – Aarehof Olten, Froburgstrasse 2, 4600 Olten

Spaces for the UK medtech seminar are limited and will be filled on a first come first served basis. For more information and to register, please see the attached PDF or visit:

Sarah Moyle, Head ofInternational Relations, Medtech Switzerland
Tel. +41 31 335 62 41, [email protected]